Histone Lactylation Drives Brain Damage in Diabetic Cognitive Decline
A novel epigenetic mechanism links excess lactate in diabetic brains to histone H4K12 lactylation, activating oxidative stress pathways in microglia.
Summary
Researchers at China-Japan Friendship Hospital discovered that hyperglycemia in type 2 diabetes elevates brain lactate, which drives a specific histone modification called H4K12 lactylation in hippocampal microglia. Using a mouse model of diabetes-associated cognitive decline (DACD), they showed this epigenetic mark enriches at the FOXO1 promoter, switching on the FOXO1/PGC-1α signaling pathway and amplifying mitochondrial oxidative stress. Blocking lactate production with a lactate dehydrogenase inhibitor reversed H4K12 lactylation and reduced downstream damage. The findings establish histone lactylation as a mechanistic bridge between metabolic dysregulation and neurological injury in diabetes.
Detailed Summary
Diabetes-associated cognitive decline (DACD) affects roughly 13–24% of diabetic adults and worsens with age, yet its molecular underpinnings remain incompletely understood. This study investigated whether excess lactate produced during hyperglycemia drives harmful epigenetic changes in brain cells, specifically through protein lactylation of histones in hippocampal microglia.
The team established a T2DM mouse model using a high-fat diet plus low-dose streptozotocin injections, then confirmed cognitive impairment via Morris water maze, novel object recognition, and novel object location tests. Brain tissue showed elevated lactate, increased pan-histone lysine lactylation (pan-Kla), neuronal apoptosis, and oxidative damage markers. Among multiple histone lactylation sites examined, H4K12la was the most significantly upregulated in hippocampal microglia of DACD mice. Parallel in vitro experiments using high-glucose and palmitate-treated primary microglia and the HMC3 human microglial line reproduced these findings.
Using CUT&Tag chromatin profiling, the researchers demonstrated that elevated H4K12la accumulates at the promoter of FOXO1, a transcription factor that controls oxidative stress responses. This epigenetic activation increased FOXO1 and its downstream target PGC-1α, promoting mitochondrial ROS production and microglial polarization toward a pro-inflammatory state. Inhibiting lactate dehydrogenase (LDH) with oxamate in high-glucose microglia substantially reduced lactate, H4K12la levels, and FOXO1 pathway activity. AAV-mediated hippocampal knockdown of FOXO1 in vivo ameliorated cognitive deficits and oxidative stress markers in diabetic mice, confirming pathway causality.
Metabolomic and proteomic profiling of hippocampal tissue provided broad support, revealing dysregulated metabolic networks consistent with mitochondrial dysfunction and glycolytic shift. The study also identified CBP and P300 as likely lactyl-transferases mediating H4K12 modification, though their relative contributions require further delineation.
These findings position H4K12 lactylation as a previously unrecognized epigenetic driver in DACD, linking the metabolic hallmark of diabetes—elevated lactate—directly to neuroinflammation and cognitive injury through a targetable chromatin mechanism. While the work is primarily in mouse and cell models, the molecular pathway is conserved, making LDHA inhibition or H4K12 lactylation modulation plausible therapeutic strategies worth exploring in human disease.
Key Findings
- Brain lactate and pan-histone lysine lactylation were significantly elevated in T2DM DACD mice and high-glucose microglia.
- H4K12la was the most upregulated histone lactylation site in hippocampal microglia of diabetic mice.
- CUT&Tag showed H4K12la enrichment at the FOXO1 promoter, activating FOXO1/PGC-1α-driven mitochondrial oxidative stress.
- LDH inhibition with oxamate reduced lactate, H4K12la, and FOXO1 pathway activity in high-glucose microglia.
- AAV-mediated hippocampal FOXO1 knockdown rescued cognitive deficits and reduced oxidative damage in DACD mice.
Methodology
The study used a HFD/STZ T2DM mouse model assessed by MWM, NOR, and NOL behavioral tests alongside HE, TUNEL, and IHC histology. Mechanistic work combined CUT&Tag chromatin profiling, quantitative proteomics/metabolomics, siRNA knockdown, AAV intracerebroventricular injection, and LDH inhibitor experiments in primary and immortalized microglial cell lines.
Study Limitations
All causal experiments were conducted in rodents or cell culture, and human validation is lacking. The specific lactyl-transferase(s) responsible for H4K12 modification were not definitively identified. The study focused on microglia, leaving contributions from neurons, astrocytes, and other cell types in DACD underexplored.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.